ArticleInternational journal of hematology2025

Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study.

Sang Eun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.